Mark B. Roth

4.6k total citations · 1 hit paper
47 papers, 3.7k citations indexed

About

Mark B. Roth is a scholar working on Molecular Biology, Aging and Endocrine and Autonomic Systems. According to data from OpenAlex, Mark B. Roth has authored 47 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Aging and 10 papers in Endocrine and Autonomic Systems. Recurrent topics in Mark B. Roth's work include Genetics, Aging, and Longevity in Model Organisms (17 papers), RNA Research and Splicing (10 papers) and Microtubule and mitosis dynamics (7 papers). Mark B. Roth is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (17 papers), RNA Research and Splicing (10 papers) and Microtubule and mitosis dynamics (7 papers). Mark B. Roth collaborates with scholars based in United States, South Africa and India. Mark B. Roth's co-authors include Karla M. Neugebauer, Alan M. Zahler, Dana L. Miller, Pamela A. Padilla, Landon L. Moore, Todd Nystul, William S. Lane, Mark W. Budde, Deborah J. Frank and Kami Ahmad and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Mark B. Roth

47 papers receiving 3.7k citations

Hit Papers

H 2 S Induces a Suspended... 2005 2026 2012 2019 2005 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark B. Roth 2.0k 789 581 542 501 47 3.7k
Christopher Hine 1.7k 0.8× 514 0.7× 564 1.0× 211 0.4× 904 1.8× 43 3.6k
Joseph A. Garcia 2.8k 1.4× 120 0.2× 120 0.2× 715 1.3× 792 1.6× 71 5.9k
Miyuki Sato 2.6k 1.3× 120 0.2× 528 0.9× 91 0.2× 543 1.1× 79 4.3k
Shifra Ben‐Dor 2.2k 1.1× 227 0.3× 68 0.1× 125 0.2× 602 1.2× 98 4.4k
Sun Hee Yim 1.4k 0.7× 142 0.2× 328 0.6× 95 0.2× 383 0.8× 39 2.6k
Ding Xue 3.9k 1.9× 77 0.1× 1.2k 2.1× 203 0.4× 398 0.8× 91 5.7k
David Hoogewijs 1.5k 0.7× 52 0.1× 329 0.6× 214 0.4× 438 0.9× 67 2.8k
Jason R. Treberg 1.9k 0.9× 231 0.3× 131 0.2× 66 0.1× 827 1.7× 77 3.7k
Leo Nijtmans 7.4k 3.6× 289 0.4× 211 0.4× 48 0.1× 618 1.2× 108 8.5k
Daniel Markovich 2.9k 1.4× 914 1.2× 40 0.1× 119 0.2× 357 0.7× 104 5.0k

Countries citing papers authored by Mark B. Roth

Since Specialization
Citations

This map shows the geographic impact of Mark B. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Roth more than expected).

Fields of papers citing papers by Mark B. Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Roth. The network helps show where Mark B. Roth may publish in the future.

Co-authorship network of co-authors of Mark B. Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Roth. A scholar is included among the top collaborators of Mark B. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Roth. Mark B. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morrison, Michael L., et al.. (2024). Exploring Iodide and Hydrogen Sulfide as ROS Scavengers to Delay Acute Rejection in MHC-Defined Vascularized Composite Allografts. Antioxidants. 13(5). 531–531. 2 indexed citations
2.
Simmons, Jon D., Olena M. Gorodnya, Mykhaylo V. Ruchko, et al.. (2017). Impact of a novel phosphoinositol-3 kinase inhibitor in preventing mitochondrial DNA damage and damage-associated molecular pattern accumulation. The Journal of Trauma: Injury, Infection, and Critical Care. 83(4). 683–689. 10 indexed citations
3.
Shawhan, R.R., Matthew J. Eckert, Shashikumar K. Salgar, et al.. (2016). Inducing metabolic suppression in severe hemorrhagic shock. The Journal of Trauma: Injury, Infection, and Critical Care. 81(6). 1003–1011. 7 indexed citations
4.
Iwata, Akiko, Michael L. Morrison, Jennifer E Blackwood, & Mark B. Roth. (2015). Selenide Targets to Reperfusing Tissue and Protects It From Injury*. Critical Care Medicine. 43(7). 1361–1367. 18 indexed citations
5.
Iwata, Akiko, Michael L. Morrison, & Mark B. Roth. (2014). Iodide Protects Heart Tissue from Reperfusion Injury. PLoS ONE. 9(11). e112458–e112458. 22 indexed citations
6.
Chan, Kin, et al.. (2010). Suspended Animation Extends Survival Limits ofCaenorhabditis elegansandSaccharomyces cerevisiaeat Low Temperature. Molecular Biology of the Cell. 21(13). 2161–2171. 4 indexed citations
7.
Miller, Dana L. & Mark B. Roth. (2009). C. Elegans Are Protected from Lethal Hypoxia by an Embryonic Diapause. Current Biology. 19(14). 1233–1237. 54 indexed citations
8.
Roth, Mark B., et al.. (2009). Adaptive Sugar Provisioning Controls Survival of C. elegans Embryos in Adverse Environments. Current Biology. 19(10). 859–863. 67 indexed citations
9.
Morrison, Michael L., et al.. (2008). Surviving Blood Loss Using Hydrogen Sulfide. The Journal of Trauma: Injury, Infection, and Critical Care. 65(1). 183–188. 71 indexed citations
10.
Roth, Mark B., et al.. (2007). SUSPENDED ANIMATION-LIKE STATE PROTECTS MICE FROM LETHAL HYPOXIA. Shock. 27(4). 370–372. 198 indexed citations
11.
Roth, Mark B., et al.. (2005). H 2 S Induces a Suspended Animation-Like State in Mice. Science. 308(5721). 518–518. 635 indexed citations breakdown →
12.
Nystul, Todd, et al.. (2003). Suspended Animation in C. elegans Requires the Spindle Checkpoint. Science. 302(5647). 1038–1041. 74 indexed citations
13.
Padilla, Pamela A., Todd Nystul, Richard A. Zager, Ali C.M. Johnson, & Mark B. Roth. (2002). Dephosphorylation of Cell Cycle–regulated Proteins Correlates with Anoxia-induced Suspended Animation inCaenorhabditis elegans. Molecular Biology of the Cell. 13(5). 1473–1483. 120 indexed citations
14.
Stear, Jeffrey H. & Mark B. Roth. (2002). Characterization of HCP-6, a C. elegans protein required to prevent chromosome twisting and merotelic attachment. Genes & Development. 16(12). 1498–1508. 73 indexed citations
15.
Neugebauer, Karla M., Joan T. Merrill, Mark H. Wener, Robert G. Lahita, & Mark B. Roth. (2000). SR proteins are autoantigens in patients with systemic lupus erythematosus: Importance of phosphoepitopes. Arthritis & Rheumatism. 43(8). 1768–1778. 75 indexed citations
16.
Stark, Jeremy M., Thomas A. Cooper, & Mark B. Roth. (1999). The Relative Strengths of SR Protein-mediated Associations of Alternative and Constitutive Exons Can Influence Alternative Splicing. Journal of Biological Chemistry. 274(42). 29838–29842. 9 indexed citations
17.
Ahmad, Kami, et al.. (1999). A histone-H3-like protein in C. elegans. Nature. 401(6753). 547–548. 217 indexed citations
18.
Tuma, Rabiya S. & Mark B. Roth. (1999). Induction of coiled body-like structures in Xenopus oocytes by U7 snRNA. Chromosoma. 108(6). 337–344. 18 indexed citations
19.
Neugebauer, Karla M. & Mark B. Roth. (1997). Transcription units as RNA processing units. Genes & Development. 11(24). 3279–3285. 100 indexed citations
20.
Yule, Terecita D., et al.. (1997). Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease. Vaccine. 15(6-7). 720–729. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026